IGM Biosciences Performance
| IGMSDelisted Stock | USD 1.27 0.03 2.31% |
The company retains a Market Volatility (i.e., Beta) of -1.03, which attests to a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning IGM Biosciences are expected to decrease slowly. On the other hand, during market turmoil, IGM Biosciences is expected to outperform it slightly. IGM Biosciences now retains a risk of 0.0%. Please check out IGM Biosciences daily balance of power, price action indicator, as well as the relationship between the semi variance and treynor ratio , to decide if IGM Biosciences will be following its current trending patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days IGM Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, IGM Biosciences is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 113.1 M | |
| Total Cashflows From Investing Activities | 64.2 M |
IGM |
IGM Biosciences Relative Risk vs. Return Landscape
If you would invest 127.00 in IGM Biosciences on November 2, 2025 and sell it today you would earn a total of 0.00 from holding IGM Biosciences or generate 0.0% return on investment over 90 days. IGM Biosciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than IGM, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
IGM Biosciences Target Price Odds to finish over Current Price
The tendency of IGM Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.27 | 90 days | 1.27 | about 38.01 |
Based on a normal probability distribution, the odds of IGM Biosciences to move above the current price in 90 days from now is about 38.01 (This IGM Biosciences probability density function shows the probability of IGM Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days IGM Biosciences has a beta of -1.03. This usually indicates Additionally IGM Biosciences has an alpha of 0.2802, implying that it can generate a 0.28 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). IGM Biosciences Price Density |
| Price |
Predictive Modules for IGM Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as IGM Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.IGM Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. IGM Biosciences is not an exception. The market had few large corrections towards the IGM Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold IGM Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of IGM Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.28 | |
β | Beta against Dow Jones | -1.03 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | 0.05 |
IGM Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of IGM Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for IGM Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| IGM Biosciences is not yet fully synchronised with the market data | |
| IGM Biosciences may become a speculative penny stock | |
| IGM Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.68 M. Net Loss for the year was (195.79 M) with loss before overhead, payroll, taxes, and interest of (5.49 M). | |
| IGM Biosciences currently holds about 469.14 M in cash with (153 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.95, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 35.0% of the company shares are held by company insiders |
IGM Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of IGM Stock often depends not only on the future outlook of the current and potential IGM Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. IGM Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 60.5 M | |
| Cash And Short Term Investments | 183.8 M |
IGM Biosciences Fundamentals Growth
IGM Stock prices reflect investors' perceptions of the future prospects and financial health of IGM Biosciences, and IGM Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IGM Stock performance.
| Return On Equity | -0.48 | |||
| Return On Asset | 0.0289 | |||
| Profit Margin | (0.37) % | |||
| Operating Margin | 0.91 % | |||
| Current Valuation | (27.73 M) | |||
| Shares Outstanding | 36.59 M | |||
| Price To Earning | (7.72) X | |||
| Price To Book | 0.76 X | |||
| Price To Sales | 0.53 X | |||
| Revenue | 2.68 M | |||
| EBITDA | (199.47 M) | |||
| Cash And Equivalents | 469.14 M | |||
| Cash Per Share | 10.95 X | |||
| Total Debt | 45.19 M | |||
| Debt To Equity | 0.09 % | |||
| Book Value Per Share | 1.68 X | |||
| Cash Flow From Operations | (153 M) | |||
| Earnings Per Share | (0.90) X | |||
| Total Asset | 265.71 M | |||
| Retained Earnings | (1.02 B) | |||
| Current Asset | 1.23 M | |||
| Current Liabilities | 3.37 M | |||
About IGM Biosciences Performance
Assessing IGM Biosciences' fundamental ratios provides investors with valuable insights into IGM Biosciences' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the IGM Biosciences is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. Igm Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 242 people.Things to note about IGM Biosciences performance evaluation
Checking the ongoing alerts about IGM Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IGM Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| IGM Biosciences is not yet fully synchronised with the market data | |
| IGM Biosciences may become a speculative penny stock | |
| IGM Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.68 M. Net Loss for the year was (195.79 M) with loss before overhead, payroll, taxes, and interest of (5.49 M). | |
| IGM Biosciences currently holds about 469.14 M in cash with (153 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.95, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 35.0% of the company shares are held by company insiders |
- Analyzing IGM Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IGM Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining IGM Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating IGM Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of IGM Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of IGM Biosciences' stock. These opinions can provide insight into IGM Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in IGM Stock
If you are still planning to invest in IGM Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IGM Biosciences' history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |